Greg Moeck
Greg Moeck publishes mostly in Infectious Diseases, Pharmacology and Molecular Medicine, on topics such as Antimicrobial Resistance in Staphylococcus, Antibiotics Pharmacokinetics and Efficacy and Antibiotic Resistance in Bacteria.
- World rank
- #1,290,235 of 7,710,434 ranked researchers
- Rank in United States
- #410,713 of 1,627,098
- Works
- 103
- Citations
- 4k
- Citations per work
- 38.3
What does Greg Moeck research?
Greg Moeck's work is mostly in Medicine (42%), Biochemistry, Genetics and Molecular Biology (30%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4341.9%
- Medicine4341.9%
- Life Sciences3029.5%
- Everything else2928.6%
- 1Infectious Diseases18% of their works
- 2Pharmacology17% of their works
- 3Molecular Medicine15% of their works
- 4Clinical Biochemistry8% of their works
- 5Molecular Biology7% of their works
- 6Epidemiology7% of their works
Research topics
- Antimicrobial Resistance in Staphylococcus
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotic Resistance in Bacteria
- Bacterial Identification and Susceptibility Testing
- Bacterial Genetics and Biotechnology
- Antibiotic Use and Resistance
- Pneumonia and Respiratory Infections
- Bacteriophages and microbial interactions
Which keywords describe Greg Moeck's research?
The keywords of their largest research topics: Antimicrobial Resistance, Epidemiology, Antibiotic Resistance, Antibiotic Pharmacokinetics, Critically Ill Patients, MRSA, Staphylococcus aureus and ESKAPE Pathogens.
- Ecology
- Global Health
- Antimicrobial Stewardship
- Bacterial Physiology
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
- ESKAPE Pathogens
- MRSA
- Antibiotic Pharmacokinetics
- Epidemiology
- Antimicrobial Resistance
- Antibiotic Resistance
- Critically Ill Patients
- Staphylococcus aureus
- Multidrug-Resistant Bacteria
- Microorganism Identification
- Gene Regulation
- Community-Acquired Pneumonia
- Pneumococcal Conjugate Vaccine
- Virus
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Antimicrobial Resistance1123 topics
- Epidemiology713 topics
- Antibiotic Resistance703 topics
- Antibiotic Pharmacokinetics511 topic
- Critically Ill Patients511 topic
- MRSA511 topic
- Staphylococcus aureus511 topic
- ESKAPE Pathogens461 topic
- Multidrug-Resistant Bacteria461 topic
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry231 topic
- Microorganism Identification231 topic
- Bacterial Physiology141 topic
- Gene Regulation141 topic
- Antimicrobial Stewardship101 topic
- Community-Acquired Pneumonia101 topic
- Global Health101 topic
- Pneumococcal Conjugate Vaccine101 topic
- Ecology91 topic
- Virus91 topic
Where does Greg Moeck work?
Greg Moeck's main affiliation in the publication record is VenatoRx Pharmaceuticals (United States), United States.
How many publications and citations does Greg Moeck have?
OpenAlex counts 103 works and 3,950 citations for Greg Moeck, an h-index of 32, ranking #1,290,235 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Greg Moeck. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.